earnings
TA
NASDAQ · TAK
Takeda Pharmaceutical Company Limited
Healthcare · Drug Manufacturers - Specialty & Generic
$18.91
Down-$0.14 (-0.73%)
Updated Sep 20, 2026, 3:17 PM
SID Score
5.8/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 45.42B
- P/E ratio
- 50.83
- Dividend yield
- 3.50%
- 52-week range
- $12.99 – $19.10
- Volume
- 2.96M
- Avg. volume
- 2.78M
Price performance
TAK price history
1M range · 19 trading sessions · Daily adjusted prices
TAK closed at $18.91 after 19 trading sessions, up 3.67% for the selected period.
- Last close
- $18.91
- Period change
- +3.67%
- Period low
- $17.98
- Period high
- $19.05
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $18.80 | $19.01 | $18.80 | $18.91 | 2.96M |
| Sep 17, 2026 | $19.02 | $19.10 | $19.00 | $19.05 | 2.71M |
| Sep 16, 2026 | $18.75 | $18.825 | $18.595 | $18.64 | 2.95M |
| Sep 15, 2026 | $18.74 | $18.765 | $18.61 | $18.70 | 2.68M |
| Sep 14, 2026 | $18.56 | $18.70 | $18.54 | $18.60 | 2.36M |
| Sep 11, 2026 | $18.38 | $18.445 | $18.20 | $18.26 | 2.15M |
| Sep 10, 2026 | $18.34 | $18.34 | $18.10 | $18.11 | 1.75M |
| Sep 9, 2026 | $18.18 | $18.35 | $18.1472 | $18.21 | 1.57M |
| Sep 8, 2026 | $18.53 | $18.65 | $18.28 | $18.32 | 3.14M |
| Sep 4, 2026 | $18.48 | $18.54 | $18.385 | $18.45 | 1.5M |
| Sep 3, 2026 | $18.75 | $18.835 | $18.52 | $18.71 | 2.85M |
| Sep 2, 2026 | $18.30 | $18.495 | $18.275 | $18.43 | 1.72M |
| Sep 1, 2026 | $18.18 | $18.405 | $18.18 | $18.23 | 1.9M |
| Aug 31, 2026 | $17.99 | $18.06 | $17.955 | $17.98 | 1.78M |
| Aug 28, 2026 | $18.00 | $18.11 | $17.96 | $18.03 | 1.81M |
| Aug 27, 2026 | $18.21 | $18.22 | $17.971 | $18.03 | 1.73M |
| Aug 26, 2026 | $18.32 | $18.38 | $18.2191 | $18.23 | 2.33M |
| Aug 25, 2026 | $18.21 | $18.355 | $18.21 | $18.35 | 1.25M |
| Aug 24, 2026 | $18.24 | $18.26 | $18.11 | $18.24 | 2.23M |
Latest TAK news
The latest Smart Investors Daily articles mentioning TAK.
Stock researchResearch & News · SEC Filings
Loading stock research…